Public Sector Pension Investment Board
PensionPosition in ACAD — Acadia Pharmaceuticals Inc
CIK 1396318
MONTREAL, A8
Position in ACAD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,014,987
+$1,044,066 QoQ
Shares Held
435,375
-2.8% QoQ
Ownership
0.253%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#50
of 354 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Public Sector Pension Investment Board holds $409,864,842 across 27 Biotechnology names. ACAD ranks #11 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
84,300 | $78,211,011 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
105,515 | $39,216,760 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
45,832 | $28,578,085 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
328,224 | $28,539,076 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
116,000 | $28,393,320 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
207,688 | $25,458,395 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
452,817 | $24,877,765 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
285,023 | $23,249,326 |
All Filings in ACAD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,014,987 | 435,375 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,970,921 | 447,930 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,572,027 | 433,247 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,392,323 | 486,988 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $9,107,975 | 422,252 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,485,058 | 390,431 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||